Bausch Health Q2 2026 earnings beat expectations, raises full-year guidance

The company reported Q2 2026 revenues of $2.85 billion, up 13%, and adjusted earnings per share of $1.26. It raised its full-year 2026 revenue, adjusted EBITDA, and adjusted cash flow guidance. CEO Thomas J. Appio highlighted the thirteenth consecutive quarter of growth despite significant net debt reduction.